Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05155956 · ClinicalTrials.gov registry record

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

A clinical trial of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection, sponsored by University of Pennsylvania.

Active
Registry status
20
Enrollment target
2
Study locations

NCT05155956 is a study of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 909-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05155956, a study of Thoracic Aortic Aneurysm and Thoracic Aortic Dissection, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

Interventions

  • OTHER transcranial Doppler ultrasonography (TCD)

Study Locations (2)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia
  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-12-15
Est. Completion 2026-12

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05155956

The ClinicalTrials.gov registry entry for NCT05155956 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 909-participant average among 7 other Thoracic Aortic Aneurysm trials with a reported enrollment target (98% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Thoracic Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which transcranial Doppler ultrasonography (TCD) is the first listed.

NCT05155956 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05155956 about?

NCT05155956 is a clinical study titled "Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System". This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

What is the current status of trial NCT05155956?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2021-12-15. Estimated completion is 2026-12.

What conditions does trial NCT05155956 study?

This clinical trial studies the following conditions: Thoracic Aortic Aneurysm, Thoracic Aortic Dissection, Microemboli.

What interventions are being tested in trial NCT05155956?

The interventions under investigation include: transcranial Doppler ultrasonography (TCD) (OTHER).

Who is sponsoring clinical trial NCT05155956?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05155956 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.